ENTITY
Luye Pharma

Luye Pharma (2186 HK)

119
Analysis
Health CareChina
Luye Pharma Group Ltd focuses on the research and development, production, and sales of pharmaceutical drugs for orthopedics, neurology, gastroenterology, and hepatology. The Company also sells active ingredients, R&D results, and patents of new drugs, as well as providing research services on a contractual basis.
more
14 Oct 2020 16:08

Simcere Pharmaceutical IPO: Valuation Insights

We think that an attractive PEG valuation and solid cornerstone support makes Simcere tempting at the proposed pricing range

Logo
543 Views
Share
27 Mar 2020 16:57

Huge Short Covering Last Week

We take a look at the latest SFC data released today evening on short position reporting in Hong Kong for the week ended 20 March 2020.Total short...

Logo
527 Views
Share
bullishAlphamab Co Ltd
03 Dec 2019 01:53

Alphamab Oncology IPO: Valuation Easy to Swallow

Alphamab Co Ltd (9966 HK) is a pre-revenue biotech company with a focus on research and development, manufacturing and commercialisation of...

Logo
623 Views
Share
14 Sep 2019 11:52

HK Short Interest - Diverging Healthcare

We analyse the latest SFC data released Friday evening on short position reporting in Hong Kong for the week ended 6 September.Total short notional...

Logo
854 Views
Share
x